The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Bailey Jeffrey Allen | Director | Grant(A) | 24K | — | $0 |
| Jun 4, 2026 | Nova Tina Susan | Director | Grant(A) | 24K | — | $0 |
| Jun 4, 2026 | Johnson Craig A | Director | Grant(A) | 24K | — | $0 |
| Jun 4, 2026 | Goetz Kathleen | Director | Grant(A) | 24K | — | $0 |
| Jun 2, 2026 | Tang Kevin | Chief Executive Officer, Director, 10% Owner | Buy(P) | 206K | $15.28 | $3.1M |
| Jun 2, 2026 | Tang Kevin | Chief Executive Officer, Director, 10% Owner | Other(J) | 10K | $1.65 | $17K |
| Jun 1, 2026 | Tang Kevin | Chief Executive Officer, Director, 10% Owner | Buy(P) | 344K | $15.28 | $5.2M |
| Jun 1, 2026 | Tang Kevin | Chief Executive Officer, Director, 10% Owner | Buy(P) | 99 | $15.34 | $2K |
| May 29, 2026 | Tang Kevin | Chief Executive Officer, Director, 10% Owner | Buy(P) | 2K | $15.35 | $35K |
| May 29, 2026 | Tang Kevin | Chief Executive Officer, Director, 10% Owner | Buy(P) | 263K | $15.31 | $4.0M |
| May 18, 2026 | Hearne Michael S | Chief Financial Officer | Grant(A) | 116K | — | $0 |
| May 18, 2026 | Hearne Michael S | Chief Financial Officer | Grant(A) | 70K | — | $0 |
| May 18, 2026 | Robertson Stephen P. | Chief Legal Officer | Grant(A) | 116K | — | $0 |
| May 18, 2026 | Cole Ryan | Chief Operating Officer | Grant(A) | 116K | — | $0 |
| May 18, 2026 | Cole Ryan | Chief Operating Officer | Grant(A) | 70K | — | $0 |
| Mar 6, 2026 | Keenan Greg | SVP, Chief Medical Officer | Tax withholding(F) | 8K | $14.32 | $116K |
| Mar 3, 2026 | Tang Kevin | Director | Buy(P) | 184K | $14.22 | $2.6M |
| Mar 2, 2026 | Tang Kevin | Director | Buy(P) | 84K | $14.33 | $1.2M |
| Mar 2, 2026 | Tang Kevin | Director | Buy(P) | 116K | $14.21 | $1.6M |
| Mar 2, 2026 | Robertson Stephen P. | EVP, General Counsel | Tax withholding(F) | 37K | $14.21 | $519K |
| Mar 2, 2026 | Greenleaf Peter | Chief Executive Officer, Director | Tax withholding(F) | 101K | $14.21 | $1.4M |
| Mar 2, 2026 | Donley Matthew Maxwell | Chief Operating Officer | Tax withholding(F) | 41K | $14.21 | $579K |
| Mar 2, 2026 | Miller Joseph M | Chief Financial Officer | Tax withholding(F) | 38K | $14.21 | $533K |
| Feb 27, 2026 | Tang Kevin | Director | Buy(P) | 215K | $14.12 | $3.0M |
| Feb 27, 2026 | Tang Kevin | Director | Buy(P) | 2K | $14.38 | $23K |
| Feb 27, 2026 | Tang Kevin | Director | Buy(P) | 300K | $13.90 | $4.2M |
| Feb 27, 2026 | Robertson Stephen P. | EVP, General Counsel | Grant(A) | 59K | — | $0 |
| Feb 27, 2026 | Robertson Stephen P. | EVP, General Counsel | Grant(A) | 99K | — | $0 |
| Feb 27, 2026 | Keenan Greg | SVP, Chief Medical Officer | Grant(A) | 41K | — | $0 |
| Feb 27, 2026 | Keenan Greg | SVP, Chief Medical Officer | Grant(A) | 68K | — | $0 |
| Feb 27, 2026 | Greenleaf Peter | Chief Executive Officer, Director | Grant(A) | 196K | — | $0 |
| Feb 27, 2026 | Greenleaf Peter | Chief Executive Officer, Director | Grant(A) | 328K | — | $0 |
| Feb 27, 2026 | Donley Matthew Maxwell | Chief Operating Officer | Grant(A) | 58K | — | $0 |
| Feb 27, 2026 | Donley Matthew Maxwell | Chief Operating Officer | Grant(A) | 97K | — | $0 |
| Feb 27, 2026 | Miller Joseph M | Chief Financial Officer | Grant(A) | 57K | — | $0 |
| Feb 27, 2026 | Miller Joseph M | Chief Financial Officer | Grant(A) | 96K | — | $0 |
| Feb 20, 2026 | Greenleaf Peter | Chief Executive Officer, Director | Tax withholding(F) | 100K | $14.40 | $1.4M |
| Feb 20, 2026 | Donley Matthew Maxwell | Chief Operating Officer | Tax withholding(F) | 33K | $14.40 | $474K |
| Feb 20, 2026 | Miller Joseph M | Chief Financial Officer | Tax withholding(F) | 32K | $14.40 | $467K |
| Feb 20, 2026 | Robertson Stephen P. | EVP, General Counsel | Tax withholding(F) | 35K | $14.40 | $499K |
| Feb 2, 2026 | Keenan Greg | SVP, Chief Medical Officer | Tax withholding(F) | 12K | $14.53 | $168K |
| Jan 2, 2026 | Greenleaf Peter | Chief Executive Officer, Director | Tax withholding(F) | 113K | $15.95 | $1.8M |
| Jan 2, 2026 | Greenleaf Peter | Chief Executive Officer, Director | Grant(A) | 165K | — | $0 |
| Jan 2, 2026 | Miller Joseph M | Chief Financial Officer | Grant(A) | 49K | — | $0 |
| Jan 2, 2026 | Miller Joseph M | Chief Financial Officer | Tax withholding(F) | 40K | $15.95 | $641K |
| Jan 2, 2026 | Donley Matthew Maxwell | Chief Operating Officer | Tax withholding(F) | 43K | $15.95 | $682K |
| Jan 2, 2026 | Donley Matthew Maxwell | Chief Operating Officer | Grant(A) | 54K | — | $0 |
| Jan 2, 2026 | Robertson Stephen P. | EVP, General Counsel | Grant(A) | 49K | — | $0 |
| Jan 2, 2026 | Robertson Stephen P. | EVP, General Counsel | Tax withholding(F) | 40K | $15.95 | $644K |
| Nov 21, 2025 | Johnson Craig A | Director | Tax withholding(F) | 6K | $15.68 | $95K |
| Nov 21, 2025 | Bailey Jeffrey Allen | Director | Tax withholding(F) | 3K | $15.68 | $43K |
| Aug 5, 2025 | Tang Kevin | Director | Buy(P) | 200K | $11.68 | $2.3M |
| Aug 4, 2025 | Tang Kevin | Director | Buy(P) | 100K | $11.34 | $1.1M |
| Aug 1, 2025 | Tang Kevin | Director | Buy(P) | 1.0M | $10.12 | $10.1M |
| Aug 1, 2025 | Keenan Greg | Chief Medical Officer | Sell(S) | 20K | $10.50 | $210K |
| May 16, 2025 | Bailey Jeffrey Allen | Director | Grant(A) | 37K | — | $0 |
| May 16, 2025 | Goetz Kathleen | Director | Grant(A) | 64K | — | $0 |
| May 16, 2025 | Johnson Craig A | Director | Grant(A) | 37K | — | $0 |
| May 16, 2025 | Nova Tina Susan | Director | Grant(A) | 64K | — | $0 |
| Mar 7, 2025 | Keenan Greg | Chief Medical Officer | Sell(S) | 8K | $8.23 | $68K |
| Mar 4, 2025 | Tang Kevin | Director | Buy(P) | 100K | $8.09 | $809K |
| Mar 4, 2025 | Tang Kevin | Director | Buy(P) | 500K | $7.92 | $4.0M |
| Mar 4, 2025 | Tang Kevin | Director | Buy(P) | 148K | $8.00 | $1.2M |
| Mar 4, 2025 | Donley Matthew Maxwell | Chief Operating Officer | Sell(S) | 59K | $7.92 | $467K |
| Mar 4, 2025 | Robertson Stephen P. | EVP, General Counsel | Sell(S) | 58K | $7.92 | $456K |
| Mar 4, 2025 | Miller Joseph M | Chief Financial Officer | Sell(S) | 56K | $7.92 | $445K |
| Mar 4, 2025 | Greenleaf Peter | Chief Executive Officer, Director | Sell(S) | 165K | $7.92 | $1.3M |
| Mar 3, 2025 | Tang Kevin | Director | Buy(P) | 101K | $7.97 | $803K |
| Mar 3, 2025 | Tang Kevin | Director | Buy(P) | 352K | $8.02 | $2.8M |
| Mar 3, 2025 | Donley Matthew Maxwell | Chief Operating Officer | Sell(S) | 66K | $8.00 | $527K |
| Mar 3, 2025 | Donley Matthew Maxwell | Chief Operating Officer | Grant(A) | 136K | — | $0 |
| Mar 3, 2025 | Robertson Stephen P. | EVP, General Counsel | Sell(S) | 65K | $8.00 | $519K |
| Mar 3, 2025 | Robertson Stephen P. | EVP, General Counsel | Grant(A) | 102K | — | $0 |
| Mar 3, 2025 | Miller Joseph M | Chief Financial Officer | Sell(S) | 62K | $8.00 | $495K |
| Mar 3, 2025 | Miller Joseph M | Chief Financial Officer | Grant(A) | 115K | — | $0 |
| Mar 3, 2025 | Keenan Greg | Chief Medical Officer | Sell(S) | 12K | $8.00 | $98K |
| Mar 3, 2025 | Greenleaf Peter | Chief Executive Officer, Director | Sell(S) | 196K | $8.00 | $1.6M |
| Mar 3, 2025 | Greenleaf Peter | Chief Executive Officer, Director | Grant(A) | 334K | — | $0 |
| Feb 28, 2025 | Tang Kevin | Director | Buy(P) | 399K | $7.85 | $3.1M |
| Feb 28, 2025 | Donley Matthew Maxwell | Chief Operating Officer | Grant(A) | 83K | — | $0 |
| Feb 28, 2025 | Donley Matthew Maxwell | Chief Operating Officer | Grant(A) | 126K | — | $0 |
| Feb 28, 2025 | Robertson Stephen P. | EVP, General Counsel | Grant(A) | 84K | — | $0 |
| Feb 28, 2025 | Robertson Stephen P. | EVP, General Counsel | Grant(A) | 128K | — | $0 |
| Feb 28, 2025 | Miller Joseph M | Chief Financial Officer | Grant(A) | 81K | — | $0 |
| Feb 28, 2025 | Miller Joseph M | Chief Financial Officer | Grant(A) | 124K | — | $0 |
| Feb 28, 2025 | Keenan Greg | Chief Medical Officer | Grant(A) | 63K | — | $0 |
| Feb 28, 2025 | Keenan Greg | Chief Medical Officer | Grant(A) | 96K | — | $0 |
| Feb 28, 2025 | Greenleaf Peter | Chief Executive Officer, Director | Grant(A) | 291K | — | $0 |
| Feb 28, 2025 | Greenleaf Peter | Chief Executive Officer, Director | Grant(A) | 444K | — | $0 |
| Dec 9, 2024 | Tang Kevin | Director | Buy(P) | 500K | $9.09 | $4.5M |
| Dec 6, 2024 | Tang Kevin | Director | Buy(P) | 400K | $9.01 | $3.6M |
| Dec 5, 2024 | Tang Kevin | Director | Buy(P) | 300K | $8.91 | $2.7M |
| Nov 21, 2024 | Jayne David R.W. | Director | Grant(A) | 12K | — | $0 |
| Nov 21, 2024 | Jayne David R.W. | Director | Grant(A) | 19K | — | $0 |
| Nov 21, 2024 | Bailey Jeffrey Allen | Director | Grant(A) | 12K | — | $0 |
| Nov 21, 2024 | Bailey Jeffrey Allen | Director | Grant(A) | 19K | — | $0 |
| Nov 21, 2024 | Johnson Craig A | Director | Grant(A) | 21K | — | $0 |
| Nov 21, 2024 | Johnson Craig A | Director | Grant(A) | 32K | — | $0 |
| Nov 21, 2024 | Leversage Jill | Director | Grant(A) | 12K | — | $0 |
| Nov 21, 2024 | Leversage Jill | Director | Grant(A) | 19K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).